| |
| |
|
| Insider
Information: |
Hanham Ann |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
38,726 |
|
|
Indirect Shares
|
3,536,660 |
|
|
| Direct
Value |
$43,892 |
|
|
|
Indirect Value
|
$398,334 |
|
|
| Total
Shares |
3,575,386 |
|
|
| Total
Value |
$442,226 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 9.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunicon Corp |
IMMCQ |
Director |
|
0 |
2004-04-21 |
350,000 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
Director |
|
0 |
2006-04-18 |
779,062 |
Premium* |
|
|
Biomimetic Therapeutics, Inc. |
BMTI |
Director, 10% Owner |
|
0 |
2006-05-11 |
2,353,433 |
Premium* |
|
|
Endocyte Inc |
ECYT |
Director |
2017-05-04 |
7,800 |
2013-05-28 |
54,165 |
Premium* |
|
|
Scynexis Inc |
SCYX |
|
2023-06-15 |
23,622 |
2016-05-25 |
0 |
Premium* |
|
|
Htg Molecular Diagnostics, Inc |
HTGM |
Director |
2019-08-14 |
7,304 |
2018-08-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
34 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2006-04-18 |
4 |
A |
$0.00 |
$0 |
I/I |
778,062 |
778,062 |
|
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Director |
– • • |
2006-05-11 |
4 |
A |
$0.00 |
$0 |
I/I |
2,353,433 |
2,353,433 |
|
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2011-02-04 |
4 |
A |
$6.00 |
$3,000,000 |
I/I |
500,000 |
38,392 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2011-02-09 |
4 |
A |
$0.00 |
$0 |
I/I |
832,735 |
102,332 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2015-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
2,250 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
4,500 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2017-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
7,800 |
0 |
- |
|
| HTGM |
Htg Molecular Diagnostics... |
Director |
– • – |
2018-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
0 |
- |
|
| HTGM |
Htg Molecular Diagnostics... |
Director |
– • – |
2018-09-11 |
4 |
A |
$4.34 |
$9,999 |
D/D |
2,304 |
4,804 |
0 |
- |
|
| HTGM |
Htg Molecular Diagnostics... |
Director |
– • – |
2019-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
7,304 |
0 |
- |
|
| SCYX |
Scynexis Inc |
Director |
– • – |
2022-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
13,622 |
0 |
- |
|
| SCYX |
Scynexis Inc |
|
• • – |
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
23,622 |
0 |
- |
|
| SCYX |
Scynexis Inc |
Director |
– • – |
2016-05-25 |
4 |
B |
$3.64 |
$15,379 |
D/D |
4,225 |
4,225 |
2.39 |
- |
|
| SCYX |
Scynexis Inc |
Director |
– • – |
2020-12-21 |
4 |
B |
$6.25 |
$20,000 |
D/D |
3,200 |
3,622 |
2.39 |
% |
|
| IMMCQ |
Immunicon Corp |
Director |
– • – |
2004-04-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,000 |
|
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2006-04-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,000 |
|
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Director |
– • • |
2006-05-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
392,701 |
|
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Director |
– • • |
2006-05-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,516,194 |
|
- |
|
| BMTI |
Biomimetic Therapeutics, ... |
Director |
– • • |
2006-05-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
444,538 |
|
- |
|
| IMMCQ |
Immunicon Corp |
Director |
– • – |
2004-04-21 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,166,667 |
350,000 |
|
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2012-05-14 |
4 |
S |
$6.94 |
$742,088 |
I/I |
(107,000) |
94,117 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2012-05-15 |
4 |
S |
$6.68 |
$267,148 |
I/I |
(40,000) |
91,046 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2012-05-16 |
4 |
S |
$6.65 |
$185,552 |
I/I |
(27,900) |
91,975 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2012-06-05 |
4 |
S |
$6.60 |
$67,350 |
I/I |
(10,200) |
88,121 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2012-06-06 |
4 |
S |
$6.60 |
$2,079,379 |
I/I |
(314,900) |
63,940 |
0 |
- |
|
34 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
